The Behavioral Economist
Behavioral finance, growth, small-cap, fund holdings

Aradigm: A Biotechnology Micro-Cap With Asymmetrical Indicators And A Noteworthy Partner

(Editors' Note: This article covers a stock trading at less than $1 per share and/or with less than a $100 million market cap. Please be aware of the risks associated with these stocks.)

The annual Biotech Showcase is an investor and partnership conference devoted to providing both private and public biopharmaceutical entities with the opportunity to capture the attention of a noteworthy audience. Each year, institutional investors, corporate executives, and reputable analysts, attend this multi-day event with observant eyes and inquisitive ears. The event is well organized, well executed, and well attended. It is an occasion often feverishly anticipated, and devotedly prepared for. For many companies, a platform such as this can be the catalyst they need to finally step...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details